The invention addresses the field of dry powder inhalers, and more specifically the drug containment systems (DCS) necessary for containment, protection and delivery of dry powder medicaments.
Materials, geometries and methods which facilitate the efficient and consistent delivery are described. Among these are features for assuring a sufficient level of DCS rigidity, and for allowing the use of integral vibratory elements for active dispersion of powder, the company said.
Paul Atkins, president and COO of Oriel, said: “This patent is part of an expanding portfolio that provides a strong intellectual property position for our range of delivery devices and their corresponding drug products.”